What are the treatment options for pain management in shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pain Management in Shingles

For acute shingles pain, start oral antivirals within 72 hours of rash onset combined with topical lidocaine 5% patches, oral acetaminophen, or NSAIDs; for postherpetic neuralgia (PHN), use gabapentin or pregabalin as first-line systemic therapy, with tricyclic antidepressants as an alternative, and reserve opioids for refractory cases.

Acute Shingles Pain Management

Antiviral Therapy (Critical First Step)

  • Initiate oral antivirals (acyclovir, famciclovir, or valacyclovir) within 72 hours of rash onset to reduce acute pain severity, duration of the eruptive phase, and risk of developing PHN 1, 2
  • Peak viral replication occurs in the first 24 hours after lesion onset, making early treatment imperative 3

Acute Pain Control

  • Topical lidocaine 5% patches applied directly to the painful site provide localized relief with minimal systemic absorption 4
  • Oral acetaminophen (up to 4,000 mg daily in divided doses) for mild to moderate pain 3
  • Oral NSAIDs for inflammatory pain component 3
  • Avoid relying solely on topical antivirals, as they provide only modest clinical benefit and require frequent application (5-6 times daily) 3

Preventive Strategy for High-Risk Patients

  • Pre-emptive low-dose tricyclic antidepressants (amitriptyline or nortriptyline 10-25 mg at bedtime) started at diagnosis of acute shingles reduces PHN incidence by approximately 50% 5
  • Consider early gabapentin initiation in patients over age 65, those with severe acute pain, or trigeminal distribution involvement 2

Postherpetic Neuralgia (PHN) Management

First-Line Systemic Agents

Anticonvulsants (preferred for neuropathic pain):

  • Gabapentin: Start 100-300 mg at bedtime, titrate by 50-100% every few days to 900-3,600 mg daily in 2-3 divided doses 3
  • Pregabalin: Start 50 mg three times daily, increase to 100 mg three times daily (maximum 600 mg daily); more efficiently absorbed than gabapentin 3, 2
  • Slower titration required for elderly or medically frail patients 3
  • Dose adjustment necessary for renal insufficiency 3

Second-Line Systemic Agents

Tricyclic Antidepressants:

  • Nortriptyline or desipramine (secondary amines, better tolerated): Start 10-25 mg nightly, increase over 2-3 weeks to 50-150 mg nightly 3, 5, 2
  • Amitriptyline (tertiary amine, more efficacious but more anticholinergic side effects): Use same dosing 3, 2
  • Expect 8 weeks for full therapeutic effect; if no relief by then, refer to pain specialist 5

Topical Therapies

  • Lidocaine 5% patches: Apply to intact skin for 12 hours, followed by 12 hours off; minimal systemic absorption makes this ideal for elderly patients 3, 4, 1, 2
  • Capsaicin cream: Effective but may cause initial burning sensation 1, 2
  • Topical agents can be combined with systemic medications for enhanced effect 4

Opioid Therapy (Reserved for Refractory Cases)

  • Tramadol as first opioid choice, particularly in patients with cardiopulmonary compromise; provides NSAID-sparing effect 3
  • Oxycodone, morphine, codeine, or hydrocodone for pain unresponsive to first-line agents 3, 1, 2
  • Use judiciously given opioid crisis concerns; titrate to lowest effective dose 3

Interventional Procedures for Refractory Pain

When to Refer

  • Refer to pain management specialist when standard pharmacologic therapy fails after 8 weeks of adequate trial 3, 5
  • Consider for patients with severe, unrelenting pain significantly impacting quality of life 6

Available Interventional Options

  • Intercostal nerve blocks to interrupt nerve conduction 3
  • Dorsal column stimulation for chronic refractory cases 3
  • TENS (transcutaneous electrical nerve stimulation) as noninvasive option, though evidence is limited 3
  • Evidence for specific interventional procedures remains inconclusive, but some patients achieve meaningful relief 6

Critical Clinical Pitfalls

  • Do not delay antiviral therapy beyond 72 hours of rash onset; efficacy drops significantly after this window 1, 2
  • Avoid monotherapy with conventional analgesics or carbamazepine for PHN—they provide little to no benefit for neuropathic pain 5
  • Do not use topical antivirals for prophylaxis—they cannot reach the site of viral reactivation in dorsal root ganglia 3
  • Monitor for anticholinergic side effects (sedation, dry mouth, urinary retention) when using tricyclic antidepressants, especially in elderly patients 3
  • Adjust gabapentin and pregabalin doses in renal insufficiency to prevent toxicity 3

Multimodal Approach

  • Combine topical and systemic therapies for additive benefit (e.g., lidocaine patches plus gabapentin) 4
  • Address psychosocial factors as pain significantly impacts quality of life and may have neuropathic, nociceptive, and psychological components 3
  • Consider physical therapy and relaxation techniques as adjuncts to pharmacologic management 3

References

Research

Management of herpes zoster and post-herpetic neuralgia.

American journal of clinical dermatology, 2013

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Topical Analgesics for Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The management of postherpetic neuralgia.

Postgraduate medical journal, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.